CHG Dressings in Children With Central Lines

Yale University

Status: Terminated

Conditions: Children With Central Venous Access

Treatments: Other: Tegaderm CHG clear dressing; Other: Standard clear Tegaderm dressing

Study type: Interventional

Funder types: Other

Identifiers

NCT01955226

Giuliano913

Details and patient eligibility

About

The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we will monitor contact skin irritation and central line associated blood stream infections.

Full description

In this prospective, randomized, cohort study, we plan on enrolling all patients 2 months to 18 years of age admitted with a central venous catheter expected to be in place for > 48 hours. Patients will be randomized to either receive 1) Tegaderm CHG clear dressing or 2) standard clear Tegaderm IV dressing. All central line care will remain uniform between the two groups as dictated by the central line maintenance bundle currently directing central line care in our children's hospital. Study completion will occur at the time of central line removal or discharge from the hospital, whichever comes first.

Enrollment: 16 patients

Sex: All

Ages: 2 months to 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All patients 2 months to 18 years of age admitted with a central venous catheter expected to be in place for > 48 hours.

Exclusion criteria

• Patients with known allergies to chlorhexidine or Tegaderm and those previously enrolled in this study will be excluded.
• Patients with portacatheters

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

16 participants in 2 patient groups

Tegaderm CHG clear dressing

Experimental group

Description:

Patients randomized to receive Tegaderm CHG clear dressing. All central line care will remain uniform between the two groups as dictated by the central line maintenance bundle currently directing central line care in our children's hospital.

Treatment:

Other: Tegaderm CHG clear dressing

Standard clear Tegaderm dressing

Active Comparator group

Description:

Patients randomized to receive standard clear Tegaderm dressing. All central line care will remain uniform between the two groups as dictated by the central line maintenance bundle currently directing central line care in our children's hospital.

Treatment:

Other: Standard clear Tegaderm dressing